SCHEMBL7113196

SCHEMBL7113196

C=CCC1CC=CC(C(=O)c2ccccc2)C1

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
AKT1 P31749 1/20 0.34
ALDH1A1 P00352 3/20 0.33
HPGD P15428 1/20 0.33
HDAC4 P56524 1/20 0.32
P2RX7 Q99572 1/20 0.31
MCL1 Q07820 1/20 0.31
MAPT P10636 1/20 0.31
ALOX15 P16050 1/20 0.31
HTT P42858 1/20 0.31
HBB P68871 1/20 0.31
POLB P06746 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
EPHX1 P07099 1/20 0.30
HTR2A P28223 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL472124 0.70 KDM4E (0.47) AKT1ALDH1A1ALOX15HTTPOLB
SCHEMBL11042013 0.66 MAPT (0.44) ALDH1A1HPGDMAPTALOX15KDM4E
SCHEMBL11042016 0.66 MAPT (0.44) ALDH1A1HPGDMAPTALOX15KDM4E
SCHEMBL1728575 0.64 GPR84 (0.43) ALDH1A1HDAC4MCL1MAPTALOX15
SCHEMBL1357104 0.63 MCL1 (0.45) ALDH1A1MCL1MAPTALOX15HTT
SCHEMBL9854916 0.63 MEN1 (0.51) LMNAMAPTPOLBGAA
SCHEMBL10526323 0.61 ELANE (0.44) ALDH1A1MAPTHTTPOLBKDM4E
SCHEMBL2039792 0.61
SCHEMBL445084 0.60 POLB (0.47) ALDH1A1MCL1MAPTALOX15HTT
SCHEMBL21895670 0.60 MCL1 (0.38) ALDH1A1MCL1MAPTALOX15HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed